These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. A randomized, double-masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis. Shulman DG, Lothringer LL, Rubin JM, Briggs RB, Howes J, Novack GD, Hart K. Ophthalmology; 1999 Feb; 106(2):362-9. PubMed ID: 9951491 [Abstract] [Full Text] [Related]
33. Disodium cromoglycate (Intal) in the treatment of vernal kerato-conjunctivitis. Easty D, Rice NS, Jones BR. Trans Ophthalmol Soc U K (1962); 1971 Feb; 91():491-9. PubMed ID: 5004367 [No Abstract] [Full Text] [Related]
35. Prophylaxis of adverse reactions to foods. A double-blind study of oral sodium cromoglycate for the prophylaxis of adverse reactions to foods and additives. Ortolani C, Pastorello E, Zanussi C. Ann Allergy; 1983 Feb; 50(2):105-9. PubMed ID: 6401954 [Abstract] [Full Text] [Related]
36. Nedocromil sodium 2% ophthalmic solution for the treatment of ragweed pollen seasonal allergic conjunctivitis. Blumenthal MN, Schwartz RH, Kaiser H. Ocul Immunol Inflamm; 2000 Sep; 8(3):159-67. PubMed ID: 11120577 [Abstract] [Full Text] [Related]
37. Ocular sodium cromoglycate. An overview of its therapeutic efficacy in allergic eye disease. Sorkin EM, Ward A. Drugs; 1986 Feb; 31(2):131-48. PubMed ID: 3081317 [Abstract] [Full Text] [Related]
38. The effect of sodium cromoglycate (SCG) in patients with food allergies. Basomba A, Campos A, Villalmanzo IG, Pelaez A. Acta Allergol; 1977 Feb; Suppl 13():95-101. PubMed ID: 415503 [No Abstract] [Full Text] [Related]
39. Double-blind trial of pentigetide ophthalmic solution, 0.5%, compared with cromolyn sodium, 4%, ophthalmic solution for allergic conjunctivitis. Kalpaxis JG, Thayer TO. Ann Allergy; 1991 May; 66(5):393-8. PubMed ID: 1903616 [Abstract] [Full Text] [Related]